Terlipressin-More than just a prodrug of lysine vasopressin?

Critical Care Medicine

Volumn 37, Issue 3, 2009, Pages 1135-1136

  Westphal, Martin ^a   Rehberg, Sebastian ^a   Ertmer, Christian ^a   Morelli, Andrea ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Myocardial function; Pharmacology; Sepsis; Systemic inflammation; Terlipressin; vasoconstriction; Vasopressin

Indexed keywords

ARGIPRESSIN; LYPRESSIN; TERLIPRESSIN; DRUG DERIVATIVE; PRODRUG; VASOCONSTRICTOR AGENT;

ANIMAL TISSUE; CONTINUOUS INFUSION; CORONARY ARTERY BLOOD FLOW; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; ENDOTOXEMIA; ENZYME RELEASE; EX VIVO STUDY; FLUID RESUSCITATION; HEART FUNCTION; HEART OUTPUT; HEART RHYTHM; HEART VENTRICLE PRESSURE; HUMAN; HUMAN TISSUE; LOW DRUG DOSE; MORTALITY; NONHUMAN; OPTIMAL DRUG DOSE; OXYGEN SATURATION; PRIORITY JOURNAL; RAT; RECOMMENDED DRUG DOSE; SEPTIC SHOCK; UNSPECIFIED SIDE EFFECT; UTERINE ARTERY; VASCULAR RING; VASOCONSTRICTION; ANIMAL; NOTE;

ANIMALS; HUMANS; LYSINE VASOPRESSIN; PRODRUGS; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 62849101892     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31819b91d5     Document Type: Editorial

References (19)

1. Dellinger RP, Levy MM, Carlet JM, et al: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327
2. Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345: 588-595
3. Russell JW, Walley KR, Singer J, et al: Vaso-pressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358:877-887
4. Scharte M, Meyer J, Van Aken H, et al: He-modynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep. Crit Care Med 2001; 29: 1756-1760
5. Asfar P, Pierrot M, Veal N, et al: Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endo-toxic rats. Crit Care Med 2003; 31:215-220
6. Asfar P, Hauser B, Ivanyi Z, et al: Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: Effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism. Crit Care Med 2005; 33:373-380
7. Leone M, Albanese J, Delmas A, et al: Terli-pressin in catecholamine-resistant septic shock patients. Shock 2004; 22:314-319
8. Morelli A, Rocco M, Conti G, et al: Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Med 2004; 30:597-604
9. Albanese J, Leone M, Delmas A, et al: Terlipressin or norepinephrine in hyperdynamic septic shock: A prospective, randomized study. Crit Care Med 2005; 33:1897-1902
10. Morelli A, Ertmer C, Lange M, et al: Continuous terlipressin versus vasopressin infusion in septic shock: The TERLIVAP study. Crit Care 2008; 12(Suppl 2):P403
11. Ertmer C, Sielenkamper AW, van Aken H, et al: Vasopressin and terlipressin in sepsis and systemic inflammatory response syndrome. Effects on microcirculation, oxygen transport, metabolism and organ function. Anaesthesist 2005; 54:346-356
12. Pesaturo AB, Jennings HR, Voils SA: Terlip-ressin: Vasopressin analog and novel drug for septic shock. Ann Pharmacother 2006; 40: 2170-2177
13. Forsling ML, Aziz LA, Miller M, et al: Conversion of triglycylvasopressin to lysinevasopressin in man. J Endocrinol 1980; 85: 237-244
14. Westphal M, Stubbe H, Sielenkamper AW, et al: Terlipressin dose response in healthy and endotoxemic sheep: Impact on cardiopulmonary performance and global oxygen transport. Intensive Care Med 2003; 29:301-308
15. Ryckwaert F, Virsolvy A, Fort A, et al: Terlip-ressin, a pro-vasopressin drug exhibits direct vasoconstrictor properties: Consequences on heart perfusion and performance. Crit Care Med 2009; 37:876-881
16. Holmes CL, Landry DW, Granton JT: Science review: Vasopressin and the cardiovascular system part 1 - Receptor physiology. Crit Care 2003; 7:427-434
17. Lange M, Koehler G, Morelli A, et al: Continuous versus bolus infusion of terlipressin in ovine endotoxemia. Shock 2007; 28:623-629
18. Landry DW, Levin HR, Gallant EM, et al: Vasopressin deficiency contributes to the va-sodilation of septic shock. Circulation 1997; 95:1122-1125
19. Nilsson G, Lindblom P, Ohlin M, et al: Pharmacokinetics of terlipressin after single i.v. doses to healthy volunteers. Drugs Exp Clin Res 1990; 16:307-314